Results 141 to 150 of about 2,128,798 (360)

The current biotechnology outlook in Malaysia [PDF]

Blessed with extremely rich biodiversity, Malaysia is all geared up to explore new high technology to utilize the advantage it possesses whilst to protect its environment.
Khairiah Salwa MOKHTAR, Ravi MAHALINGAM
core  

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source

Panel report: Biotechnology Resources Program (BRP) [PDF]

, 1976
William R. Baker
openalex   +1 more source

Biotechnology business in Norway: Peripheral advantage, or just periphery? [PDF]

Research on biotechnology related firms has long been associated with the agglomeration of “dedicated biotechnology firms” and partners such as large corporations, research institutes and venture capital firms.
Terje Grønning
core  

Expression and purification of E140 protein antigen fragments of Plasmodium vivax and Plasmodium berghei for serological assays

FEBS Open Bio, EarlyView.
We provide a step‐by‐step guide for producing E140 antigen fragments from Plasmodium berghei (Pb1) and Plasmodium vivax (Pv1). Pb1/Pv1 are expressed in E. coli, solubilized by freeze–thawing, refolded by slow dilution, purified by affinity chromatography (IMAC), then concentrated and subjected to quality control.
Rodolfo Ferreira Marques, Edit Ábrahám, Hiromi Muramatsu, Daniel Youssef Bargieri, Norbert Pardi, Zoltán Lipinszki   +5 more
wiley   +1 more source

Proprietary Rights and the Norms of Science in Biotechnology Research [PDF]

, 1987
Rebecca S. Eisenberg
openalex   +1 more source

In memoriam

Genetics & Applications, 2019
Institute for Genetic Engineering and Biotechnology
doaj   +1 more source

Yeast Biotechnology 6.0

Fermentation
This Special Issue continues the “Yeast Biotechnology” Special Issue series of the MDPI journal Fermentation [...]
Ronnie G. Willaert
doaj   +1 more source

UNCOVERING FACTORS INFLUENCING PUBLIC PERCEPTIONS OF FOOD BIOTECHNOLOGY [PDF]

Significant divergence exists in public opinions about biotechnology. Although there is broad support for plant biotechnology for health benefits, opinions differ on the issue of animal genetics for pure economic benefits.
Adelaja, Adesoji O., Hallman, William K., Hossain, Ferdaus, Onyango, Benjamin M., Schilling, Brian J.   +4 more
core   +1 more source